ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670782 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670782; 2) Community: the network communities that were significantly associated with the response to NSC 670782; 3) Molecule: the relationships between components within communities and NSC 670782; 4) MDR: the compounds that were significantly associated with the NSC 670782.

NSC Compound Enrichment Correlation
NSC 728040 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline 0.0462077035966084 0.50845155
NSC 736079 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine 0.0462077035966084 0.41885936
NSC 736081 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine 0.0462077035966084 0.35703644
NSC 758965 CEPHARANTHINE 0.0462077035966084 0.30324989
NSC 79304 Null 0.0462077035966084 0.50024292
NSC 99027 Null 0.0462077035966084 0.33450418
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0462077035966088 0.16022957
NSC 671888 Null 0.046717891610184 0.54647613
NSC 677942 L-Glutamamide, N(2)-[4-[[(2,4-diamino-6-pteridinyl)methyl](methyl)amino]benzoyl]-N(1),N(5)-didecyl- 0.046717891610184 0.37451834
NSC 680410 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, tricyclo[3.3.1.13,7]dec-1-yl ester (9CI) 0.046717891610184 0.55258261
Total:114  Current:110    [First] [Prev] [Next] [Last]